List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 21 studies with search of:   Mozambique
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting Comparison of Nevirapine and Efavirenz for the Treatment of HIV-TB co-Infected Patients (ANRS 12146 CARINEMO)
Conditions: Tuberculosis;   AIDS;   HIV Infections
Interventions: Drug: Nevirapine based therapy;   Drug: Efavirenz based therapy;   Drug: Rifampicin (RMP) Ethambutol (E) Isoniazid (H) Pyrazinamid (Z)
2 Completed Combination Antimalarials in Uncomplicated Malaria
Condition: Malaria
Interventions: Drug: Sulfadoxine-pyrimethamine;   Drug: Artesunate plus sulfadoxine-pyrimethamine;   Drug: Artemether-lumefantrine
3 Completed A Randomised Efficacy Study of Combination Antimalarials to Treat Uncomplicated Malaria
Condition: Malaria
Interventions: Drug: Sulfadoxine-pyrimethamine;   Drug: Artesunate plus sulfadoxine-pyrimethamine
4 Completed A Randomised Efficacy Study of Combination Antimalarials to Treat Uncomplicated Malaria
Condition: Malaria
Interventions: Drug: Sulfadoxine-pyrimethamine;   Drug: Artesunate plus sulfadoxine-pyrimethamine
5 Active, not recruiting Artesunate Plus Sulfadoxine-Pyrimethamine Pharmacokinetics, Efficacy, Gametocytes Carriage and Birth Outcomes in Pregnant Women With Malaria
Condition: Malaria
Intervention: Drug: Artesunate plus sulfadoxine-pyrimethamine
6 Completed Longitudinal Study of HAART, Social Networks, & Adherence
Condition: Acquired Immunodeficiency Syndrome
Intervention: Behavioral: modified directly observed therapy (mDOT)
7 Completed Influence of Transmission Season on Outcome of Treatment of Schistosoma Haematobium Infection in Mozambique
Conditions: Hematuria;   Hydronephrosis
Intervention: Drug: praziquantel
8 Completed Long-Term Follow-up of Children for a 2-Year Period to Confirm the Safety and Immunogenicity of GSK 257049 Vaccine
Conditions: Plasmodium Falciparum;   Malaria
Interventions: Drug: amodiaquine;   Biological: GSK Biologicals' candidate Plasmodium falciparum malaria vaccine 257049;   Biological: Engerix B;   Biological: Hiberix;   Biological: Prevnar;   Drug: sulfadoxine-pyrimethamine
9 Completed Examine Safety & Immune Responses of GSK 257049 Vaccine When Administered to Infants Living in a Malaria-Endemic Region
Conditions: Plasmodium Falciparum;   Malaria
Interventions: Biological: Engerix B®;   Biological: GSK Biologicals' candidate Plasmodium falciparum malaria vaccine 257049;   Biological: TETRActHibTM
10 Recruiting Multicenter Trial for the Evaluation of a Fixed Dose Combined Tablet for the Treatment of Pulmonary Tuberculosis
Condition: Tuberculosis
Intervention: Drug: combined fixed dose combination
11 Completed A Study to Evaluate the Safety, Immunogenicity and Efficacy of GlaxoSmithKline (GSK) Biologicals' Candidate Malaria Vaccine RTS,S/AS02A, When Administered to Children Aged 1 to 4 Years Living in a Malaria-Endemic Region of Mozambique.
Condition: Plasmodium Falciparum
Intervention: Biological: RTS,S/AS02A
12 Active, not recruiting Pharmacokinetics, Efficacy, Gametocyte Carriage, Birth Outcomes Following Sulfadoxine-Pyrimethamine Intermittent Presumptive Treatment in Pregnant Women
Condition: Malaria
Intervention: Drug: sulfadoxine-pyrimethamine
13 Recruiting Age of Exposure and Immunity to Malaria in Infants
Condition: Malaria
Intervention: Drug: Sulfadoxine-pyrimethamine (SP)
14 Completed Misoprostol for the Treatment of Incomplete Abortion
Condition: Abortion, Incomplete
Interventions: Drug: misoprostol;   Procedure: MVA
15 Completed A Study to Evaluate the Safety and Immunogenicity of GSK Biologicals' Candidate Vaccines RTS,S/AS02D (0.5 mL Dose) and RTS,S/AS02A (0.25 mL Dose) Administered IM According to a 0, 1, 2 Month Vaccination Schedule in Children Aged 3 to 5 Years Living in a Malaria-Endemic Region of Mozambique.
Condition: Plasmodium Falciparum
Intervention: Biological: RTS,S/AS02D and RTS,S/AS02A
16 Recruiting Evaluation of 4 Artemisinin-Based Combinations for Treating Uncomplicated Malaria in African Children
Conditions: Fever;   Malaria
Interventions: Drug: amodiaquine-artesunate (ASAQ);   Drug: dihydroartemisinin-piperaquine (DHAPQ);   Drug: artemether-lumefantrine (AL);   Drug: Lapdap (Chlorproguanil-Dapsone) + artesunate (AS)
17 Recruiting Routine Iron Prophylaxis During Pregnancy
Condition: Anemia During Pregnancy
Intervention: Procedure: Two policies of iron prophylaxis
18 Active, not recruiting IPTp Plus ITNs for Malaria Control in Pregnant Women
Condition: Pregnancy
Interventions: Drug: Sulfadoxine-Pyrimethamine (Fansidar);   Device: ITNs
19 Completed Pyronaridine Artesunate (3:1) Versus Coartem® in P Falciparum Malaria Patients
Condition: Malaria
Interventions: Drug: Pyronaridine artesunate;   Drug: Coartem® (artemether lumefantrine)
20 Recruiting Pyronaridine Artesunate 3:1 Granule Formulation vs. Coartem© Crushed Tablets in P. Falciparum Malaria Pediatric Patients
Condition: Malaria
Interventions: Drug: pyronaridine artesunate;   Drug: arthemeter lumefantrine

Previous Page Studies Shown (1-20) Next (21-21)
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services